Assay Development

The process of proving an assay to be sensitive with respect to the target is known as assay development. The assay should be able to characterize novel compounds and measure the potency of these compounds against a validated biological target.

Latest content and products

Editorial ArticleDrug Discovery & Development

Mechanism-linked potency assays drive gene therapy success

VectorBuilder’s Alan Griffith explains the value of MoA-reflective potency assays for gene therapy development and the benefits of working with assay specialists like Svar Life Science

25 Nov 2025

Industry NewsDrug Discovery & Development

Synthace collaborates with Charles River to offer the global pharma industry more robust, faster and cost-effective assays

9 Feb 2026

Product NewsClinical Diagnostics

QuidelOrtho receives FDA 510(k) clearance for its VITROS syphilis assay

4 Sept 2024

Product NewsClinical Diagnostics

Roche granted FDA Breakthrough Device Designation

23 May 2024

Webinars

Smart engineering strategies to future proof your system development

Speakers: Allen Garner, Plexus, Grant Gardner, Plexus, Luke Palombo, Plexus, Matilde Marques, SelectScience

18 Feb 2026

Watch on-demand

Why oligo optimization and validation is key for your assay’s lifetime performance

Speakers: Lindy McClelland, LGC Biosearch Technologies, Matilde Marques, SelectScience

25 Sept 2025

Watch on-demand

Quantitative measurement solutions for flow cytometry

Speakers: Virginia Litwin, Ph.D., Eurofins Clinical Trial Solutions, Susmita Jasti, Ph.D., Eurofins Clinical Trial Solutions

16 Apr 2025

Watch on-demand

Roadmap to successful drug therapy partnerships

Speakers: Cara Begg, Eurofins Central Laboratory , Dr. Katryn Allen, Eurofins Bioanalytical Services, Carrie Haslam, SelectScience

28 Aug 2024

Watch on-demand

Editorial Articles

Editorial Article

Mechanism-linked potency assays drive gene therapy success

25 Nov 2025

Editorial Article

Bioanalytic breakthroughs redefine drug development

30 Apr 2024

Editorial Article

‘Google Maps’ for the human body – How spatial genomics is revolutionizing our understanding of disease

18 Feb 2024

Editorial Article

Partner with bioanalytical MS/MS experts to overcome biomarker assay challenges

19 Dec 2023

Latest Videos

Experience ADLM 2024 with SelectScience

SelectScience Interviews

Experience ADLM 2024 with SelectScience

29 Aug 2024

Made for affinity measurements. Built for momentum. Monolith X.

Product Demonstrations

Affinity measurements with the Monolith X

4 Jun 2024

Resources

Screenshot of the Sphera™ lyobead dispensing system data sheet

Product Brochures

Sphera™ lyobead dispensing system data sheet

27 Nov 2025

Application Note

Accelerate your assay development with ZeptoMetrix

24 Apr 2025

Product Brochures

Making the move to automated liquid handling

10 Apr 2025

Application Note

Detection of Human Fc Fusion Proteins with Cyto-Mine

26 Mar 2025

News

Markus Gershater, Synthace

Industry News

Synthace collaborates with Charles River to offer the global pharma industry more robust, faster and cost-effective assays

9 Feb 2026

Industry News

Fujirebio Europe introduces PreCursor-M AnoGYN assay

5 Mar 2024

Industry News

Aptamer and Neuro-Bio enter the second phase of Alzheimer’s test development

23 Feb 2024

Industry News

Fujirebio expands its Alzheimer’s disease test menu

22 Dec 2023

Assay Development